NASDAQ:CTSO
Cytosorbents Corporation Stock News
$0.88
+0.0606 (+7.40%)
At Close: May 03, 2024
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Cytosorbents Corp (CTSO) Q1 2020 Earnings Call Transcript
07:01pm, Wednesday, 06'th May 2020
Joining me today from the company are: Dr. Phillip Chan, Chief Executive Officer; Vincent Capponi, Chief Operating Officer; Kathleen Bloch, Chief Financial Officer; Dr. Efthymios Makis Deliargyris, Ch
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
CytoSorbents Reports First Quarter 2020 Financial and Operational Results
08:15pm, Tuesday, 05'th May 2020
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery pati
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
CytoSorbents Promotes Vincent J. Capponi to President
11:08am, Monday, 04'th May 2020
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Cytosorbents: COVID-19 Has Presented A Bullish Opportunity
08:56am, Wednesday, 29'th Apr 2020
Cytosorbents’ flagship product, CytoSorb can help interrupt the cytokine storm seen in COVID-19 patients with acute respiratory distress syndrome. Cytokine stor
CytoSorbents Reports $1.1M In Non-Dilutive Funding From New Jersey Business Tax Certificate Transfer Program
12:00am, Wednesday, 29'th Apr 2020
So far Tuesday, April 28, NASDAQ is down -7.41% and the S&P is down -3.87%. Let’s take a look at
CytoSorbents to Report Q1 2020 Operating and Financial Results
12:00pm, Tuesday, 28'th Apr 2020
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac su
The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update
11:36am, Tuesday, 28'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 27)
AstraZeneca plc (NYSE: AZN...
Stocks That Hit 52-Week Highs On Monday
02:21pm, Monday, 27'th Apr 2020
During Monday's morning session, these companies made new 52-week highs.
Noteworthy Points:
The largest company by market cap to set a new 52-week high was Novo Nordisk...
Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer
11:08am, Monday, 27'th Apr 2020
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac su
